Alvotech (ALVO) vs Supernus Pharmaceuticals, Inc. (SUPN)
- Alvotech ALVO 5.00 −5.84%
- Supernus Pharmaceuticals, Inc. SUPN 37.88 −4.27%
Alvotech and Supernus Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Supernus Pharmaceuticals, Inc. is the larger, with a market value of $2.3B against $2.1B — 1.1× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against 24.9%. Supernus Pharmaceuticals, Inc. has the higher net margin (−13.2% vs −101.1%) and the lower return on invested capital (−12.4% vs 0.00%). Across the 16 metrics below, Supernus Pharmaceuticals, Inc. leads on 10 and Alvotech on 6.
Valuation
Profitability
| Metric | ALVO | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 88.07% | 53.94% |
| Operating margin | (42.43%) | (15.71%) | 0.00% |
| Net margin | (101.05%) | (13.23%) | 0.00% |
| Free cash flow margin | 0.00% | 2.21% | 0.00% |
| Return on equity | 0.00% | (10.49%) | (0.40%) |
| Return on assets | 0.00% | (7.82%) | (3.32%) |
| Return on invested capital | 0.00% | (12.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack